Back to search

Article

Treprostinil in the treatment of pediatric patients with severe Idiopathic and Heritable Pulmonary Arterial Hypertension

2023-03-22

Abstract excerpt

<h4>Introduction: </h4> Data have been accumulating that parental treprostinil is safe and effective in pediatric PAH patients. This study was designed to evaluate the efficacy of treprostinil in severe pediatric patients with IPAH and HPAH (IPAH/HPAH). <h4>Methods:</h4> Children diagnosed with IPAH/HPAH between August 2018 to April 2022 treated with treprostinil at a single center were included in this study. Cli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c80bfcd7-fc2d-591b-80bf-69781da217c2
DOI
10.21203/rs.3.rs-2664529/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treprostinil in the treatment of pediatric patients with severe Idiopathic and Heritable Pulmonary Arterial HypertensionDOI 10.21203/rs.3.rs-2664529/v1
Select a neighboring publication to make it the new centre.